Trial NCT02599090

View at ClinicalTrials.gov 
Org. Study IDs: 2008-0059 Phase II
Secondary IDs: NCI-2012-01617

Last trial update was posted on 2015-11-06

MeSH Interventions

Sorafenib Temozolomide

MeSH Conditions

Glioblastoma Gliosarcoma

Other Conditions


Stopping Reasons

Multi phase study did not progress to Phase II. Phase I registered as NCT00734526.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID